About this trial
The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
Eligibility criteria
Qualifiers
Participants that will be or are admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit
Ages 0-17 years
Participants that are at high risk for undergoing ECMO or are currently undergoing venovenous or venoarterial ECMO
Undergoing cardiac surgery
Disqualifiers
Pregnancy
Pacemaker
Implanted defibrillator
Implanted insulin pump
Trial design
Treatments tested in this trial
- Hyperfine
Treatment groups
Locations
1Sponsors and collaborators
Children's Mercy Hospital Kansas City
Lead sponsor